Hello. Thank you for visiting our store, we buy things in a licensed pharmacy in the European Union.

PIASCLEDINE contains unsaponifiable oils from avocado and soybean.
PIASCLEDINE belongs to the group of drugs of slow-acting symptomatic therapy "SYSADOA" (symptomatic slow-acting drugs in osteoarthritis, SYSADOA), for the treatment of osteoarthritis, characterized by a significantly delayed effect. Therefore, when starting to use PIASCLEDINE, it may be necessary to take tablets in combination with NSAIDs and/or analgesics - the dose of which will most likely need to be reduced as the effect of PIASCLEDINE increases.
PIASCLEDINE is used in adults to relieve symptoms of osteoarthritis of the knee, such as pain and difficulty moving.
The full effect of PIASCLEDINE can be observed after several weeks and usually continues after treatment is stopped.
If after 2 - 3 months you do not feel better or feel worse, you should consult your doctor.

Compound
Active ingredients: unsaponifiable oils of avocado and soybeans. Each capsule contains 300 mg of unsaponifiable avocado and soybean extract, which corresponds to 100 mg of unsaponifiable avocado oil and 200 mg of unsaponifiable soybean oil.

Usage
Adults: The recommended dose is one capsule per day with food. The effects of PIASCLEDINE can be observed after a few weeks. If you feel that the effect of the medicine is not working quickly enough, do not stop treatment without consulting your doctor or pharmacist. Children and teenagers: PIASCLEDINE should not be used in children and adolescents under 18 years of age, since safety and effectiveness in this group have not been established. Directions for use: Oral administration. The capsule should be swallowed whole, without chewing, with a glass of water with meals. Duration of treatment: In clinical trials, patients received PIASCLEDINE for up to 3 years. Patients should continue treatment as long as it is well tolerated and symptoms continue to improve. Unless specifically directed by your doctor, take this medication for at least 3 months for long-term treatment of osteoarthritis symptoms, but not longer than 6 months.